Discover how proteomics data analysis and bioinformatics tools enhance mass spectrometry workflows for robust findings.
Allied Market Research published a report, titled, "Genomics Market by Product (Consumables and Reagent, Services, ...
Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...
Interstellar Semantics LLC Launches in Frederick, Maryland, Bringing Advanced Semantic and Ontology Expertise to Data Driven Organizations ...
Insilico Medicine and MSK collaborate to discover new drug targets for gastroesophageal malignancies
Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery ...
SOPHiA Genetics announces major expansion in US with the signing of two major integrated health systems: Boston, Massachusetts Thursday, February 12, 2026, 17:00 Hrs [IST] SOPHiA ...
Amman, Jordan – Cloud Solutions IT and Communications is pleased to announce a strategic collaboration with the Kingdom ...
LIGAND-AI is a flagship project of the Target 2035 initiative, funded by the Innovative Health Initiative, a public-private partnership (PPP) between the European Union and the European life science ...
GlobalData on MSN
RNA-targeting small molecules: a new frontier of drug discovery
With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.
Learn how Kamogelo Mmereke is taking her cancer research to the global stage with the UN, showcasing South African innovation and leadership in science diplomacy.
Researchers used advanced imaging to uncover early molecular changes in bone that may enable earlier diagnosis of ...
Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results